Q4 2026 Zydus Wellness Ltd Earnings Call Transcript
Key Points
- Zydus Wellness Ltd (BOM:531335) reported a significant net sales growth of 62.1% for Q4 FY26, with international business showing a like-to-like growth of 31.4%.
- The company successfully expanded its product portfolio with new launches in the RiteBite Max Protein franchise, Sugar Free D'lite, Everyuth, and Glucon-D, enhancing its presence in the wellness and healthy snacking space.
- The domestic business witnessed a shift towards organized channels, with saliency improving to 30% in FY26 from 24% in FY25, driven by premiumization and growth in modern trade and e-commerce.
- Zydus Wellness Ltd (BOM:531335) reported a 42.2% growth in EBITDA for the quarter, indicating strong operational performance despite challenges.
- The company is leveraging AI-led consumer targeting and data-driven media allocation to optimize spends and enhance returns on brand investments, positioning itself for sustainable growth.
- Net profit declined by 5.8% during the quarter and 43.2% for the year, highlighting profitability challenges despite revenue growth.
- The domestic seasonal brands declined by 9.8% in Q4 FY26, impacted by unfavorable weather conditions and inventory issues.
- The company faced higher depreciation and amortization expenses due to the amortization of acquired brands, affecting overall profitability.
- Zydus Wellness Ltd (BOM:531335) experienced challenges in the seasonal portfolio, with delayed summer impacting sales and inventory buildup.
- Despite a larger revenue base, the company is tracking lower than its near-term aspiration of 17% to 18% EBITDA margin, indicating room for improvement in operational efficiency.
Ladies and gentlemen, good day, and welcome to the Zydus Wellness Limited Q4 FY26 results conference call. (Operator Instructions) I now hand the conference over to Akshay Krishnan. Thank you, and over to you.
it's an absolute pleasure from ICICI Securities to host the Q4 FY26 earnings call for Zydus Wellness. From the management, we are being represented by Dr. Sharvil Patel, the Chairman; Mr. Ganesh Nayak, the Non-Executive Director; Mr. Tarun Arora, CEO; Mr. Umesh Parikh, the CFO. I hand over the call to the management for the further remarks. Thank you, and over to you, sir.
Good evening, and welcome to the post results teleconference of Zydus Wellness Limited for quarter four, financial year 2025-'26. Like Akshay mentioned, I have with me Dr. Sharvil Patel, Chairman; Mr. Ganesh Nayak, Director; and Mr. Umesh Parikh, CFO, on the call from our side.
During the quarter, consumption
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
